癌变·畸变·突变
癌變·畸變·突變
암변·기변·돌변
CARCINOGENSES,TERATOGENSIS AND MUTAGENESIS
2014年
4期
258-260,265
,共4页
刘海英%黄青%董静文%李莉
劉海英%黃青%董靜文%李莉
류해영%황청%동정문%리리
Oct4%miR-302%胚胎癌细胞%启动子
Oct4%miR-302%胚胎癌細胞%啟動子
Oct4%miR-302%배태암세포%계동자
Oct4%miR-302 cluster%embryonic carcinoma cells%promoter
目的:检测胚胎癌F9细胞中Oct4对miR-302启动子活性是否具有调节作用。方法:构建PGL3-P-miR-302启动子荧光素酶报告基因质粒并验证其活性,然后将0.5μg PGL3-P-miR-302分别与0.5和1.0 g Oct4表达质粒共转染至293T细胞中,检测过表达Oct4对miR-302启动子活性的影响;并将0.5μg PGL3-P-miR-302和Oct4 siRNA(2.0μg siRNA1和2.0μg siRNA2)共转染到F9细胞中,检测Oct4 RNA干扰对miR-302启动子活性的影响,以验证Oct4对miR-302启动子是否有调控作用。结果:成功构建了PGL3-P-miR-302启动子荧光素酶报告基因质粒,并证实了PGL3-P-miR-302在F9细胞中具有启动子活性;在T293细胞中,当Oct4表达质粒为0.5μg时miR-302启动子转录活性是对照组的2.6倍(P<0.05),当Oct4为1.0μg时miR-302启动子转录活性是对照组的4.3倍(P<0.05);在F9细胞中miR-302启动子的活性在转染Oct4 siRNA后明显下降,约为siRNA非特异性对照组的68%(P<0.05)。结论:Oct4对miR-302启动子具有正调节作用,miR-302可能是Oct4的靶基因之一。
目的:檢測胚胎癌F9細胞中Oct4對miR-302啟動子活性是否具有調節作用。方法:構建PGL3-P-miR-302啟動子熒光素酶報告基因質粒併驗證其活性,然後將0.5μg PGL3-P-miR-302分彆與0.5和1.0 g Oct4錶達質粒共轉染至293T細胞中,檢測過錶達Oct4對miR-302啟動子活性的影響;併將0.5μg PGL3-P-miR-302和Oct4 siRNA(2.0μg siRNA1和2.0μg siRNA2)共轉染到F9細胞中,檢測Oct4 RNA榦擾對miR-302啟動子活性的影響,以驗證Oct4對miR-302啟動子是否有調控作用。結果:成功構建瞭PGL3-P-miR-302啟動子熒光素酶報告基因質粒,併證實瞭PGL3-P-miR-302在F9細胞中具有啟動子活性;在T293細胞中,噹Oct4錶達質粒為0.5μg時miR-302啟動子轉錄活性是對照組的2.6倍(P<0.05),噹Oct4為1.0μg時miR-302啟動子轉錄活性是對照組的4.3倍(P<0.05);在F9細胞中miR-302啟動子的活性在轉染Oct4 siRNA後明顯下降,約為siRNA非特異性對照組的68%(P<0.05)。結論:Oct4對miR-302啟動子具有正調節作用,miR-302可能是Oct4的靶基因之一。
목적:검측배태암F9세포중Oct4대miR-302계동자활성시부구유조절작용。방법:구건PGL3-P-miR-302계동자형광소매보고기인질립병험증기활성,연후장0.5μg PGL3-P-miR-302분별여0.5화1.0 g Oct4표체질립공전염지293T세포중,검측과표체Oct4대miR-302계동자활성적영향;병장0.5μg PGL3-P-miR-302화Oct4 siRNA(2.0μg siRNA1화2.0μg siRNA2)공전염도F9세포중,검측Oct4 RNA간우대miR-302계동자활성적영향,이험증Oct4대miR-302계동자시부유조공작용。결과:성공구건료PGL3-P-miR-302계동자형광소매보고기인질립,병증실료PGL3-P-miR-302재F9세포중구유계동자활성;재T293세포중,당Oct4표체질립위0.5μg시miR-302계동자전록활성시대조조적2.6배(P<0.05),당Oct4위1.0μg시miR-302계동자전록활성시대조조적4.3배(P<0.05);재F9세포중miR-302계동자적활성재전염Oct4 siRNA후명현하강,약위siRNA비특이성대조조적68%(P<0.05)。결론:Oct4대miR-302계동자구유정조절작용,miR-302가능시Oct4적파기인지일。
To investigate whether Oct4 could activate miR-302 promoter in the F9 mouse embryonic carcinoma cells. METHODS:PGL3-P-miR-302 was created by cloning the PCR-amplified region of the miR-302 putative promoter. PGL3-P-miR-302 promoter reporter plasmids (0.5 μg) were co-transfected with 0.5μg or 1.0μg Oct4 expression vector into 293T cells. PGL3-P-miR-302 promoter reporter plasmids (0.5μg) were co-transfected with Oct4 siRNA(2.0μg siRNA1 and 2.0μg siRNA2) into F9 cells. Luciferase activity was assayed. RESULTS:PGL3-P-miR-302 was created,and the cell-specific activity of this promoter was identified by its transfection into F9 cells. With 0.5 μg and 1.0 μg Oct4 overexpression in 293T cells,miR-302 promoter activity increased 2.6-fold and 4.3-fold,respectively. After siRNA-mediated knockdown of Oct4,miR-302 luciferase activity fell to 68% compared with control siRNA. CONCLUSION:This study showed that the miR-302 cluster acted downstream of the Oct4 regulation network in F9 cells.